William H. Kucheman

Hank Kucheman serves as a Senior Advisor or Board Member to various public and private medical device and healthcare companies, including Global Health Exchange. Mr. Kucheman previously served as Chief Executive Officer for Boston Scientific, focused on leading global markets for less-invasive medical devices by developing and marketing innovative products, services and therapies that address unmet patient needs, provide superior clinical outcomes and demonstrate proven economic value. Before being named CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular (CRV) Group and was responsible for the Company’s Interventional Cardiology and Cardiac Rhythm Management businesses and its Endovascular Unit, which includes the Peripheral Interventions, Neurovascular, and Imaging and Electrophysiology businesses. He joined the Company in 1995 as a result of Boston Scientific’s acquisition of SCIMED Life Systems, Inc. As Senior Vice President of Marketing for Boston Scientific, Mr. Kucheman was responsible for the global marketing functions of the Company’s Cardiovascular Group and corporate marketing functions. During his tenure, he oversaw the commercialization strategy for the Company’s TAXUS® paclitaxel-eluting coronary stent system, defined and developed the Boston Scientific Reimbursement and Outcomes Planning functions, and initiated Marketing Science and e-Marketing programs. He was promoted to Senior Vice President and Group President of the Company’s Cardiovascular Group prior to his role in overseeing Boston Scientific’s CRV Group. Before joining Boston Scientific, Mr. Kucheman held a variety of management positions in sales and marketing for SCIMED, Charter Medical Corporation and Control Data Corporation. He began his career at the United States Air Force Academy Hospital and later was Healthcare Planner, Office of the Surgeon General, for the United States Air Force Medical Service. Mr. Kucheman earned a BS and MBA from Virginia Polytechnic Institute and State University.